Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model. [electronic resource]
Producer: 20191121Description: E16-E33 p. digitalISSN:- 1522-1555
- Androgen Antagonists -- pharmacology
- Animals
- Apolipoprotein B-100 -- drug effects
- Apolipoprotein B-48 -- drug effects
- Apolipoproteins B -- drug effects
- Blood Glucose -- drug effects
- Cardiovascular Diseases
- Disease Models, Animal
- Estrogen Receptor alpha -- drug effects
- Female
- Flutamide -- pharmacology
- Follicular Phase
- Hypoglycemic Agents -- pharmacology
- Insulin -- metabolism
- Insulin Resistance
- Intestinal Mucosa -- metabolism
- Liver -- drug effects
- Metabolic Syndrome -- metabolism
- Metformin -- pharmacology
- Mitogen-Activated Protein Kinase 1 -- drug effects
- Ovarian Follicle -- drug effects
- Ovary -- drug effects
- Polycystic Ovary Syndrome -- metabolism
- Proto-Oncogene Proteins c-akt -- drug effects
- RNA, Messenger
- Rats
- Receptor, Insulin -- drug effects
- Risk
- Triglycerides -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.